$3.07
-4.1%SBC Medical Group Holdings Incorporated provides management services to cosmetic treatment centers in Japan, Vietnam, the United States, and internationally. The company offers advertising and marketing services; staff management services, such as recruitment and training; booking reservations for franchisee clinic customers; assistance with franchisee employee housing rentals and facility rentals; construction and design of franchisee clinics; medical equipment; and medical consumables procurement. It provides IT software solutions; breast augmentation, liposuction, and rejuvenation treatments, including treatment of wrinkles, acne, scars, cellulite, excess fat, discoloration, and signs of aging; laser skin toning and spot removal; eyes double fold surgery; rhinoplasty; treatment of osmidrosis and hyperhidrosis; hair transplants; gynecological formation treatments; laser hair removal; face line surgeries; cosmetical dental procedures; tattoo removal; lasik eye surgery; lateral canthoplasty; brow lift procedures; androgenetic alopecia treatment; and cheek sagging prevention methods. The company was founded in 2000 and is headquartered in Irvine, California.
Moderate conversion rate. Some gap between earnings and cash flow may warrant investigation into working capital or non-cash items.
Asset-light business model. Low capital requirements leave more cash available for shareholders and growth investments.
Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.
Moderate working capital outflow. Typical for growing businesses, but ensure it's supporting revenue growth, not inefficiency.
Working capital strain: Significant cash tied up in operations. Monitor receivables collection, inventory turns, and payment terms to optimize cash conversion cycle.
SBC โข NASDAQ
| SBC Medical Group Holdings Incorporated Cash Flow Statement | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 |
|---|---|---|---|---|
OPERATING ACTIVITIES | ||||
51M | 46.6M | 39.4M | 5.6M | |
2.7M | 3.8M | 12.2M | 5.9M | |
5.3M | -14.4M | 4.1M | -3.9M | |
0.0 | 13M | 0.0 | 0.0 | |
-7.8M | -16.3M | 2.6M | 3M | |
(0.0) | (30.2M) | (17.8M) | (30.8M) | |
-12.3M | -12.1M | -7.7M | -10.6M | |
38.9M | 20.6M | 50.6M | -47.4K | |
INVESTING ACTIVITIES | ||||
-2.8M | -3.4M | -9.5M | -24.9M | |
-15.5M | -5.1M | (722.6K) | -6.5M | |
-21.1M | -331.5K | -2.1M | -2.6M | |
0.0 | 0.0 | 4.1M | 0.0 | |
18.3M | -1.3M | 8.6M | 1.4M | |
-21M | -10.1M | (1.8M) | -32.7M | |
FINANCING ACTIVITIES | ||||
-5M | 31.4K | 10.0 | 118.8M | |
18.8M | 6.5M | 3.6M | -5.1M | |
-5M | (0.0) | (0.0) | (0.0) | |
10.2M | 16.4M | 2.6M | -121.7M | |
24M | 23M | 6.1M | -8M | |
CASH FLOW SUMMARY | ||||
-3.3M | -11.4M | -7.3M | -12.1M | |
38.7M | 22M | 51.3M | -52.8M | |
125M | 103M | 51.7M | 104.5M | |
163.8M | 125M | 103M | 51.7M | |
36.6M | 17.2M | 39.4M | -25M |
SBC - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | May 28, 2026 | May 28, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 20, 2026 | May 14, 2026 | 2026 | |
10-Q 10-Q 2026 Q1 Q1 | May 14, 2026 | March 31, 2026 | 2026 | |
8-K 8-K 2026 N/A | May 14, 2026 | May 14, 2026 | 2026 | |
10-K/A 10-K/A 2025 FY (Amended) FY | April 30, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | April 23, 2026 | April 19, 2026 | 2026 | |
10-K 10-K 2025 FY FY | March 27, 2026 | December 31, 2025 | 2025 | |
8-K 8-K 2026 N/A | March 27, 2026 | March 27, 2026 | 2026 | |
8-K 8-K 2026 N/A | January 05, 2026 | January 05, 2026 | 2026 | |
8-K 8-K 2025 N/A | December 31, 2025 | December 31, 2025 | 2025 |
Continue your SBC research with focused valuation guides.
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.